By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


EKR Therapeutics, Inc. 

7 East Frederick Place

Cedar Knolls  New Jersey  07927  U.S.A.
Phone: 877-435-2524 Fax: 866-254-1491



Start Up

Company News
Cornerstone Therapeutics Inc. Completes Acquisition of EKR Therapeutics, Inc. 6/27/2012 9:04:40 AM
Cornerstone Therapeutics Inc. Reports First Quarter 2012 Financial Results 5/15/2012 9:03:52 AM
Cornerstone Therapeutics Inc. to Acquire EKR Therapeutics, Inc. for $125 Million Cash, Plus $25 Million in Milestones 5/15/2012 6:47:57 AM
EKR Therapeutics, Inc. Names Two Independent Directors and Reaffirms Board of Directors to Lead Company Growth in the Critical Care Sector 12/15/2011 9:45:16 AM
EKR Therapeutics, Inc. Announces Robert P. Roche Jr. Joins Board of Directors 10/24/2011 10:07:47 AM
EKR Therapeutics, Inc. Announces Senior Management Change 10/14/2011 9:28:36 AM
Rolf A. Classon Joins Board of EKR Therapeutics, Inc. 5/13/2011 10:16:21 AM
EKR Therapeutics, Inc. Release: New Study Demonstrates Ready-to Use Cardene(R) I.V. More Effective than Labetalol for Immediate Control of Blood Pressure in Emergency Room Patients 9/29/2010 8:08:10 AM
EKR Therapeutics, Inc. Names John E. Bailye New Chief Executive Officer 7/22/2010 10:31:39 AM
EKR Therapeutics, Inc. Appoints John Bailye as Interim President & Chief Executive Officer 3/4/2010 6:57:06 AM